Mitochondrial-driven alterations of the epigenome have been reported but whether they are relevant at the organismal level remain unknown. The viable yellow agouti mouse (A vy ) is a powerful epigenetic biosensor model that reports on the DNA methylation status of the A vy locus through the coat color of the animals. Here we show that maternal exposure to rotenone, a potent mitochondrial complex I inhibitor, changes the DNA methylation status of the A vy locus and broadly affects the liver DNA methylome of the offspring. These effects were accompanied by altered gene expression programs that persisted throughout life. Mitochondrial dysfunction was present in the mothers but not in the offspring until 12 months of age, when electron transport and antioxidant defenses were impaired. These results highlight a putative novel role for mitochondria in nuclear epigenetic remodeling during development, raising fundamental questions about the long-term impact of mitochondrial dysfunction to health and disease.3 Mitochondrial function affects many areas of cell biology but its impact on epigenetics has just lately gained attention. A decade ago, changes in DNA methylation as a function of mitochondrial DNA (mtDNA) content were first reported (1), and only recently has mitochondrial dysfunction resulting from progressive mtDNA depletion or complex III mutations been shown to alter the histone methylation and acetylation landscapes (2-4).In this context, it was recently shown that the DNA methylation and histone acetylation changes associated with mitochondrial dysfunction influenced gene expression programs. Importantly, these epigenetic and transcriptional effects could be reversed by modulating the tricarboxylic acid (TCA) cycle through genetic or pharmacological means (3,4). Activation of the methionine salvage pathway was involved in DNA methylation changes while mitochondrial-derived acetyl-CoA was found to influence the histone acetylation landscape (3,4). Other links between mitochondrial metabolism and the epigenome involving increased reactive oxygen species (ROS) or altered abundance of other TCA cycle metabolites such as α-ketoglutarate or 2-hydroxyglutarate have also been proposed (2, 5). Still, the physiological relevance of the effects of mitochondrial dysfunction on epigenetics in vivo remains ill-defined.The viable yellow agouti mouse (A vy ) is an epigenetic biosensor model that has been widely used in the field of environmental epigenetics. One of its advantages is that the DNA methylation status of the A vy locus influences the coat color of the animals, which can be used as a visual screen to evaluate DNA methylation in vivo (6). Furthermore, because the epigenetic state of the A vy locus is established before the 3-germ layer separation (7-9), the DNA methylation status of A vy in the skin reflects the methylation state of the locus in other tissues as well (9). Most notably, work on this animal model has 4 shown that maternal exposure to different diets, physical or chemical agents such as bisphenol A ...